Researchers with City of Hope and MSK have created a tool that uses machine learning to assess a non-Hodgkin lymphoma (NHL) patient’s likely response to chimeric antigen receptor (CAR) T cell therapy ...

Background Annually, 4% of the global population undergoes non-cardiac surgery, with 30% of those patients having at least one cardiovascular risk factor. It is estimated that the 30-day mortality is ...

A new article outlines a new tool that measures blood inflammation as a marker for poor CAR T therapy outcomes. Researchers with City of Hope, one of the largest and most advanced cancer research and ...

Machine learning can help predict whether people newly diagnosed with MS will experience disability worsening that occurs ...

Rainfall prediction has advanced rapidly with the adoption of machine learning, but most models remain optimized for overall ...